Adenosine Testing to DEtermine the Need for Pacing Therapy

Newcastle-upon-Tyne Hospitals NHS Trust52 enrolled

Overview

The purpose of this study is to determine whether or not the intravenous adenosine test readily identifies patients with unexplained syncope who would benefit from permanent pacemaker implantation.

The investigation of syncope (transient loss of consciousness with loss of postural tone, collapse and spontaneous recovery) varies widely, is often lengthy and frequently expensive. The intravenous adenosine test has been used in the investigation of syncope and is cheap, safe and free of serious side effects. However, it is unclear what diagnosis the test unearths. There is some evidence that the test readily identifies bradycardia pacing indications. In this study we plan to perform the adenosine test and implant a pacemaker should the test be positive. In half of the patients we will turn the pacemaker "on" and in the other half the pacemaker "off". The groups will swap over after six months. During this time we will assess the number of syncopal episodes. Also, in those who have a negative adenosine test we will implant a loop recorder to try to discover the cause of syncope.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

Conditions

Syncope

Interventions

Pacemaker implantation (Medtronic)DEVICE

DDD+/-R pacing

Pacemaker implantation (Medtronic)DEVICE

ODO pacing

Implantable Loop Recorder (Medtronic)DEVICE

Loop recorder implantation

Eligibility

Sex: ALLMin age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Episode of syncope * Patient has provided written informed consent for participation in the study prior to any study specific procedures * Male or female * Age \> 40 years * No cause of syncope clearly identified on clinical examination, lying and standing blood pressure measurements and standard 12 lead ECG. Exclusion Criteria: * Asthma or chronic obstructive pulmonary disease * Severe coronary disease (myocardial infarction within 3 months, known coronary stenosis \>70%, NYHA heart failure or angina symptoms Class III or IV) * Known severe cerebrovascular disease or known significant internal carotid artery stenosis (\>70%) * Prolonged corrected QT interval * Unablated accessory pathway * Pregnancy or lactation * Use of dipyridamole or any rate-limiting medication that cannot be safely discontinued * Hypertrophic cardiomyopathy * Cardiac transplantation * Concurrent participation in another investigational study or trial * Inability to give informed consent; carer/proxy assent will be allowed in this study * Cause of syncope established from initial clinical history and examination, lying and standing blood pressure and ECG

Locations (2)

Royal Victoria Infirmary

Newcastle upon Tyne, Tyne and Wear, United Kingdom

Feeeman Hospital

Newcastle upon Tyne, Tyne and Wear, United Kingdom

Outcomes

Primary Outcomes

Syncope Burden

Syncope Burden as measured by number of syncopal episodes and recorded by weekly postal patient diaries with telephone reminders to ensure adequate return

Time frame: 12 months

Secondary Outcomes

Time to first syncope

Time frame: 12 months

Number of patients with recurrent syncope

Number of patients with \>1 episodes of syncope

Time frame: 12 months

Quality of life

Quality of life as measured via the condition-specific instrument the Impact of Syncope on Quality of Life questionnaire with general health-related quality of life measured via the WHOQoL-Brief and WHOQoL-Old instruments

Time frame: 12 months

Health economic analysis

Costs and benefits of the intervention to health and social services. (i) Use of EQ-5D questionnaire to establish the cost per Quality Adjusted Life Year (QALY) (ii) The analysis will include the patients described above as well as a historical comparator group of consecutive patients derived from the database held by the Falls and Syncope Service who have not undergone adenosine testing. This group is particularly important to establish the utility of adenosine testing in the diagnosis of unexplained syncope.

Time frame: 12 months

ECG diagnosis on ILR following syncopal episode in adenosine negative group

ECG diagnosis on ILR following syncopal episode in intravenous adenosine test negative group

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.